Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor

被引:45
作者
Phelps, R
Robbins, K
Liberti, T
Machuca, A
Leparc, G
Chamberland, M
Kalish, M
Hewlett, I
Folks, T
Lee, LM
McKenna, M
机构
[1] Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA USA
[2] Natl Ctr HIV STD & TB Prevent, Div AIDS STD & TB Lab Res, Atlanta, GA USA
[3] Ctr Dis Control, Natl Ctr Infect Dis, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA
[4] Ctr Dis Control & Prevent, Atlanta, GA USA
[5] Florida Dept Hlth, Tallahassee, FL USA
[6] US FDA, CBER, Mol Biol Lab,Off Blood Res & Review, Div Emerging & Transfus Transmitted Dis, Bethesda, MD USA
[7] Florida Blood Serv, St Petersburg, FL USA
关键词
D O I
10.1111/j.1537-2995.2004.03364.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Pooled NAT and donor screening have reduced the diagnostic window period for HIV in the blood donor population to approximately 10 to 15 days. This report describes two cases of transfusion-acquired HIV infection and verification of transmission from the donor to the recipients, and attempts to identify how the 18-year-old donor acquired her infection. STUDY DESIGN AND METHODS: After a repeat donor had a positive HIV test result, two recipients of the donor's previous donation were identified and tested. The donor and recipients were interviewed and blood samples were obtained for HIV DNA sequencing and phylogenetic analysis. RESULTS: The two recipients had positive HIV test results. Phylogenetic analysis showed a high genetic similarity among the viruses (bootstrap 100%), consistent with transmission from the donor to the recipients. Four of five men with whom the donor had sexual contact during the critical time period when infection most likely occurred were located and tested; results were negative for HIV. CONCLUSIONS: Pooled NAT of blood donations has not eliminated the window period for HIV identification during seroconversion.
引用
收藏
页码:929 / 933
页数:5
相关论文
共 19 条
[1]   Safety of the blood supply in the United States: Opportunities and controversies [J].
AuBuchon, JP ;
Birkmeyer, JD ;
Busch, MP .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (10) :904-909
[2]  
Busch M. P., 2000, Transfusion (Bethesda), V40, P143
[3]   Current and emerging infectious risks of blood transfusions [J].
Busch, MP ;
Kleinman, SH ;
Nemo, GJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (08) :959-962
[4]   GENETIC-RELATIONSHIPS DETERMINED BY A DNA HETERODUPLEX MOBILITY ASSAY - ANALYSIS OF HIV-1 ENV GENES [J].
DELWART, EL ;
SHPAER, EG ;
LOUWAGIE, J ;
MCCUTCHAN, FE ;
GREZ, M ;
RUBSAMENWAIGMANN, H ;
MULLINS, JI .
SCIENCE, 1993, 262 (5137) :1257-1261
[5]  
DELWART EL, 2002, 9 C RETR OPP INF FEB
[6]   Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population [J].
Dodd, RY ;
Notari, EP ;
Stramer, SL .
TRANSFUSION, 2002, 42 (08) :975-979
[7]   HIV infection in women in the United States - Status at the millennium [J].
Hader, SL ;
Smith, DK ;
Moore, JS ;
Holmberg, SD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (09) :1186-1192
[8]   The incidence window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection [J].
Kleinman, S ;
Busch, MP ;
Korelitz, JJ ;
Schreiber, GB .
TRANSFUSION MEDICINE REVIEWS, 1997, 11 (03) :155-172
[9]   Genotyping HIV-1 and HCV strains by a combinatorial DNA melting assay (COMA) [J].
Kostrikis, LG ;
Shin, S ;
Ho, DD .
MOLECULAR MEDICINE, 1998, 4 (07) :443-453
[10]   Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States [J].
Lackritz, EM ;
Satten, GA ;
AberleGrasse, J ;
Dodd, RY ;
Raimondi, VP ;
Janssen, RS ;
Lewis, WF ;
Notari, EP ;
Petersen, LR .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1721-1725